To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Knee OA: Single (1200 mg) and 3/day (400 mg) dose chondroitin are equivalent

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2013

Knee OA: Single (1200 mg) and 3/day (400 mg) dose chondroitin are equivalent

Vol: 2| Issue: 7| Number:288| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study

Osteoarthritis Cartilage. 2012 Oct 8. pii: S1063-4584(12)00992-2. doi: 10.1016/j.joca.2012.09.017

Contributing Authors:
B Zegels P Crozes D Uebelhart O Bruyere JY Reginster

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

353 patients with knee osteoarthritis (OA) were randomized to receive a single oral dose of a 1200 mg sachet of chondroitin 4&6 sulfate (CS 1200) daily, three capsules of chondroitin 4&6 sulfate 400 mg (CS 3*400) daily or placebo. Over 3 months, the groups that received CS 1200 and CS 3*400 demonstrated greater improvement in pain and functioning than the placebo group. However, there was no signi...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue